Design Therapeutics, Inc.DSGNNASDAQ
Loading
EV/EBITDA Over TimeStrong
Percentile Rank83
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-6.61
↑ 99% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-1185.67
Historical baseline
PeriodValueYoY Change
2025-6.61+1.5%
2024-6.71-242.0%
2023-1.96+77.5%
2022-8.73+54.7%
2021-19.29+85.8%
2020-136.04+98.3%
2019-8120.37-